NO169285C - Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinforbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinforbindelser

Info

Publication number
NO169285C
NO169285C NO873731A NO873731A NO169285C NO 169285 C NO169285 C NO 169285C NO 873731 A NO873731 A NO 873731A NO 873731 A NO873731 A NO 873731A NO 169285 C NO169285 C NO 169285C
Authority
NO
Norway
Prior art keywords
compounds
piperide
preparation
therapeutically active
analogy procedure
Prior art date
Application number
NO873731A
Other languages
English (en)
Norwegian (no)
Other versions
NO169285B (no
NO873731L (no
NO873731D0 (no
Inventor
Leif Helth Jensen
Per Sauerberg
Frank Waetjen
Jens William Kindtler
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK426986A external-priority patent/DK426986D0/da
Priority claimed from DK597186A external-priority patent/DK597186D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO873731D0 publication Critical patent/NO873731D0/no
Publication of NO873731L publication Critical patent/NO873731L/no
Publication of NO169285B publication Critical patent/NO169285B/no
Publication of NO169285C publication Critical patent/NO169285C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO873731A 1986-09-08 1987-09-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinforbindelser NO169285C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK426986A DK426986D0 (da) 1986-09-08 1986-09-08 Piperidine forbindelser, deres fremstilling og anvendelse
DK597186A DK597186D0 (da) 1986-12-12 1986-12-12 Heterocykliske forbindelser, deres fremstilling og anvendelse

Publications (4)

Publication Number Publication Date
NO873731D0 NO873731D0 (no) 1987-09-07
NO873731L NO873731L (no) 1988-03-09
NO169285B NO169285B (no) 1992-02-24
NO169285C true NO169285C (no) 1992-06-03

Family

ID=26067417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873731A NO169285C (no) 1986-09-08 1987-09-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinforbindelser

Country Status (17)

Country Link
US (2) US4837241A (de)
EP (1) EP0259621B1 (de)
JP (1) JPH0662616B2 (de)
KR (1) KR950009366B1 (de)
AT (1) ATE82751T1 (de)
AU (1) AU603603B2 (de)
CA (1) CA1340937C (de)
DE (1) DE3782785T2 (de)
ES (1) ES2043624T3 (de)
FI (1) FI86424C (de)
GR (1) GR3007053T3 (de)
IE (1) IE62485B1 (de)
IL (1) IL83275A (de)
NO (1) NO169285C (de)
NZ (1) NZ221672A (de)
PH (1) PH23584A (de)
PT (1) PT85650B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
EP0322034A3 (de) * 1987-12-22 1991-01-02 Merck Sharp & Dohme Ltd. Methyltetrahydropyridyloxadiazole
IL88846A0 (en) * 1988-01-08 1989-07-31 Merck Sharp & Dohme Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
EP0459568A3 (en) * 1990-05-31 1992-09-30 Merck Sharp & Dohme Ltd. Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use
MX9100517A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
ATE164519T1 (de) * 1990-11-29 1998-04-15 Allergan Inc Verwendung von pyridine derivate zur behandlung der okulären hypertomie
US5175166A (en) * 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists
EP0619814A1 (de) * 1991-12-31 1994-10-19 Fujisawa Pharmaceutical Co., Ltd. Oxadiazolderivate mit acetycholinesterase-hemmender und muscarin-agonistischer wirkung
US5424301A (en) * 1993-02-01 1995-06-13 Warner-Lambert Company Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
EP0637586B1 (de) * 1993-08-05 1999-06-02 HOECHST MARION ROUSSEL, Inc. 2-(Piperidin-4-yl, Pyridin-4-yl und Tetrahydropyridin-4-yl)-benzofuran-7-carbamat Derivate, ihre Herstellung und Verwendung als Acetylcholinesterase Inhibitoren
US5753683A (en) * 1993-08-19 1998-05-19 Novo Nordisk A/S Antipsychotic method
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5821371A (en) * 1994-10-24 1998-10-13 Eli Lilly And Comany Heterocyclic compounds and their preparation and use
US5726193A (en) * 1994-10-31 1998-03-10 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
EP1014974B1 (de) 1997-05-29 2004-08-11 H. Lundbeck A/S Behandlung der schizophrenie und der psychose
WO1999032486A1 (en) * 1997-12-23 1999-07-01 Alcon Laboratories, Inc. Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
US7332508B2 (en) * 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
NZ548693A (en) * 2004-02-18 2010-05-28 Astrazeneca Ab Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2005080394A1 (en) * 2004-02-24 2005-09-01 Bioaxone Therapeutique Inc. 4-substituted piperidine derivatives
US8084473B2 (en) 2007-04-24 2011-12-27 Solvay Pharmaceuticals B.V. Heterocyclic compounds with affinity to muscarinic receptors
MX2009011499A (es) * 2007-04-24 2009-11-09 Solvay Pharm Bv Compuestos heterociclicos con afinidad por los receptores muscarinicos.
EP2296471A4 (de) 2008-05-15 2012-03-14 Univ Toledo Muskarinsäureagonisten als kognitive enhancer
US9549928B2 (en) 2011-04-29 2017-01-24 The University Of Toledo Muscarinic agonists as enhancers of cognitive flexibility
US10149856B2 (en) 2015-01-26 2018-12-11 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10857157B2 (en) 2015-01-26 2020-12-08 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10106525B2 (en) 2015-01-26 2018-10-23 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US11198680B2 (en) 2016-12-21 2021-12-14 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US10537567B2 (en) 2017-07-11 2020-01-21 BioAxone BioSciences, Inc. Kinase inhibitors for treatment of disease
WO2020206410A1 (en) * 2019-04-04 2020-10-08 University Of Maryland, Baltimore Methods of using muscarinic antagonists in the treatment of depression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966748A (en) * 1975-05-08 1976-06-29 American Cyanamid Company Para-fluorophenyl-N-heterocyclic substituted butanes
US4518601A (en) * 1982-06-16 1985-05-21 Ciba Geigy Corporation 2-(3-Pyridyl)-1,3,4-oxadiazoles and use thereof in pest control
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders

Also Published As

Publication number Publication date
NZ221672A (en) 1990-09-26
DE3782785T2 (de) 1993-04-01
US4933353A (en) 1990-06-12
EP0259621A3 (en) 1988-10-12
ATE82751T1 (de) 1992-12-15
NO169285B (no) 1992-02-24
DE3782785D1 (de) 1993-01-07
EP0259621B1 (de) 1992-11-25
PT85650A (en) 1987-10-01
US4837241A (en) 1989-06-06
FI86424C (fi) 1992-08-25
NO873731L (no) 1988-03-09
KR950009366B1 (ko) 1995-08-21
AU7816587A (en) 1988-03-31
EP0259621A2 (de) 1988-03-16
FI86424B (fi) 1992-05-15
JPH0662616B2 (ja) 1994-08-17
FI873809A (fi) 1988-03-09
JPS6377877A (ja) 1988-04-08
IE62485B1 (en) 1995-02-08
AU603603B2 (en) 1990-11-22
IL83275A0 (en) 1987-12-31
IE872173L (en) 1989-03-08
IL83275A (en) 1994-02-27
GR3007053T3 (de) 1993-07-30
KR880003939A (ko) 1988-06-01
FI873809A0 (fi) 1987-09-02
NO873731D0 (no) 1987-09-07
CA1340937C (en) 2000-03-28
ES2043624T3 (es) 1994-01-01
PT85650B (pt) 1990-05-31
PH23584A (en) 1989-09-11

Similar Documents

Publication Publication Date Title
NO169285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinforbindelser
ATE172201T1 (de) Morphinan-derivate und medizinische verwendung
ATE121744T1 (de) Neue triazolopyrimidin- und pyrazolopyrimidinderivate zur behandlung von kachexie.
FI875666A (fi) Menetelmä terapeuttisesti aktiivisen kinoliiniyhdisteen valmistamiseksi
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
ES2068216T3 (es) Compuestos de tienotriazolodiazepina y usos farmaceuticos de los mismos.
DE3879429D1 (de) Cyclopropanderivate.
DK297485D0 (da) Carbapenemer med kvaternaere heteroarylalkylthio 2-substituenter samt laegemiddel indeholdende saadanne forbindelser
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
NO173865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,3,4,5-tetrahydro-1h-3-benzazepiner
FI900231A0 (fi) Cyklohexanacetaminderivat.
DK248484D0 (da) Isoquinolinderivater
DE3650311D1 (de) Verwendung von Quinazolinen zur Herstellung eines Arzneimittels zur Behandlung und Vorbeugung von Arrhythmie.
DK444087A (da) Piperidinforbindelser, deres fremstilling og anvendelse
ES2033859T3 (es) Acidos y esteres 2-amino-3-aroil-gamma-oxobencenbutanoicos.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MARCH 2002